Table 2.
Occurrence of AF Documented by ECG and Atrial High‐Rate Episodes Device‐Detected, Including Antiarrhythmic and Antithrombotic Therapy
| Total Population | Remote Group | Control Group | ||||
|---|---|---|---|---|---|---|
| (n = 300) | (n = 150) | (n = 150) | ||||
| Number of | Odds Ratio for | |||||
| Type of Detection of AF | Events (%) | AF Occurrence | 95% CI | P Value | ||
| AF documented by ECG | 21 (7) | 15 (10) | 6 (4) | 2.67 | 1.01‐7.07 | 0.042 |
| AHREs device‐detected | 63 (21.0) | 35 (23.3) | 28 (18.7) | 1.33 | 0.76‐2.32 | 0.321 |
| AF management | Therapeutics options applied at least once during follow‐up | |||||
| N total (n = 65) | Remote group (36) | Control group (29) | Odds Ratio for | |||
| Patients with AF | Number of patients (%) | AF management | 95% CI | P Value | ||
| No therapy | 17 (26.2) | 5 (13.8) | 12 (41.3) | |||
| Amiodarone | 14 (21.5) | 8 (22.2) | 6 (20.6) | 1.34 | 0.45‐3.97 | 0.593 |
| Antithrombotic therapy (ASA or warfarin) | 48 (73.8) | 31 (86.1) | 17 (58.6) | 2.53 | 1.26‐5.08 | 0.008 |
| Electrical cardioversion | 13 (20.0) | 8 (22.2) | 5 (17.2) | 1.63 | 0.52‐5.11 | 0.400 |
Abbreviations: ASA = acetylsalicylic acid; ECG = electrocardiogram; AF = atrial fibrillation; AHREs = atrial high‐rate episodes; CI = confidence interval.